VKTXW - (Viking Therapeutics Inc.)

 VKTXWのチャート


 VKTXWの企業情報

symbol VKTXW
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear ―年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/vktxw
adr_tso
EBITDA EBITDA ー
終値(lastsale) 13.0749
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 VKTXWのテクニカル分析


 VKTXWのニュース

   Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly  2021/04/06 13:07:55 Benzinga
The following article is sponsored by Actinium Pharmaceuticals, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. As science advances in terms of finding new treatments for unmet medical needs, certain approaches are not appropriate for specific types of patients. For example, when it comes to older patients, often certain treatments can be counterproductive, leaving them vulnerable and without a way to combat the disease. In the biotech world, many are racing to give people solutions and hope for a better future. While we are ages from having prompt answers, companies like Fortress Biotech, Inc. (NASDAQ: FBIO ), Viking Therapeutics (NASDAQ: VKTX ), Onconova Therapeutics (NASDAQ: ONTX ), Fusion Pharmaceuticals Inc (NASDAQ: FUSN ), Gilead Sciences, Inc. (NASDAQ: GILD ) and Bristol-Myers Squibb (NYSE: BMY ), among others, are on the front lines of this race.
   Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update  2021/02/17 21:05:00 PR Newswire
SAN DIEGO, Feb. 17, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the fourth quarter and year…
   Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17, 2021  2021/02/10 21:05:00 PR Newswire
SAN DIEGO, Feb. 10, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for…
   The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO  2021/01/28 13:03:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 27) Abbott Laboratories (NYSE: ABT ) (reacted to fourth-quarter results) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Aziyo Biologics Inc (NASDAQ: AZYO ) Cassava Sciences Inc (NASDAQ: SAVA ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Frequency Therapeutics Inc (NASDAQ: FREQ ) (reacted to ratings upgrade by JPMorgan to Overweight) Fulgent Genetics Inc (NASDAQ: FLGT ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc. (NASDAQ: ILMN ) ImmuCell Corporation (NASDAQ: ICCC ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Kaleido Biosciences Inc (NASDAQ: KLDO ) LeMaitre Vascular Inc (NASDAQ: LMAT ) Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Nantkwest Inc (NASDAQ: NK ) Penumbra Inc (NYSE: PEN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Rubius Therapeutics Inc (NASDAQ: RUBY ) Silence Therapeutics ADR Representing 3 Ord Shs (NASDAQ: SLN ) Summit Therapeutics Inc (NASDAQ: SMMT ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Tenax Therapeutics Inc (NASDAQ: TENX ) Vanda Pharmaceuticals Inc.
   Viking Therapeutics Announces Senior Management Team Appointments  2021/01/06 21:05:00 PR Newswire
SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced two key executive promotions. The company has named…
   Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly  2021/04/06 13:07:55 Benzinga
The following article is sponsored by Actinium Pharmaceuticals, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. As science advances in terms of finding new treatments for unmet medical needs, certain approaches are not appropriate for specific types of patients. For example, when it comes to older patients, often certain treatments can be counterproductive, leaving them vulnerable and without a way to combat the disease. In the biotech world, many are racing to give people solutions and hope for a better future. While we are ages from having prompt answers, companies like Fortress Biotech, Inc. (NASDAQ: FBIO ), Viking Therapeutics (NASDAQ: VKTX ), Onconova Therapeutics (NASDAQ: ONTX ), Fusion Pharmaceuticals Inc (NASDAQ: FUSN ), Gilead Sciences, Inc. (NASDAQ: GILD ) and Bristol-Myers Squibb (NYSE: BMY ), among others, are on the front lines of this race.
   Viking Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update  2021/02/17 21:05:00 PR Newswire
SAN DIEGO, Feb. 17, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the fourth quarter and year…
   Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2020 on February 17, 2021  2021/02/10 21:05:00 PR Newswire
SAN DIEGO, Feb. 10, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for…
   The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO  2021/01/28 13:03:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 27) Abbott Laboratories (NYSE: ABT ) (reacted to fourth-quarter results) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Aziyo Biologics Inc (NASDAQ: AZYO ) Cassava Sciences Inc (NASDAQ: SAVA ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Frequency Therapeutics Inc (NASDAQ: FREQ ) (reacted to ratings upgrade by JPMorgan to Overweight) Fulgent Genetics Inc (NASDAQ: FLGT ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc. (NASDAQ: ILMN ) ImmuCell Corporation (NASDAQ: ICCC ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Kaleido Biosciences Inc (NASDAQ: KLDO ) LeMaitre Vascular Inc (NASDAQ: LMAT ) Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Nantkwest Inc (NASDAQ: NK ) Penumbra Inc (NYSE: PEN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Rubius Therapeutics Inc (NASDAQ: RUBY ) Silence Therapeutics ADR Representing 3 Ord Shs (NASDAQ: SLN ) Summit Therapeutics Inc (NASDAQ: SMMT ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Tenax Therapeutics Inc (NASDAQ: TENX ) Vanda Pharmaceuticals Inc.
   Viking Therapeutics Announces Senior Management Team Appointments  2021/01/06 21:05:00 PR Newswire
SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced two key executive promotions. The company has named…

 関連キーワード  (― 米国株 VKTXW Viking Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)